Phase 1b/2a Study Investigating ATX-101 in Combination With Platinum-based Chemotherapy in Platinum-sensitive, Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancer
Latest Information Update: 19 Feb 2024
At a glance
- Drugs ATX 101 (Primary) ; Carboplatin (Primary) ; Doxorubicin (Primary) ; Gemcitabine (Primary)
- Indications Carcinoma; Endometrial cancer; Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors Therapim
- 13 Feb 2024 Status changed from recruiting to discontinued.
- 17 Jul 2022 Status changed from not yet recruiting to recruiting.
- 21 Jun 2021 Planned initiation date changed from 30 Apr 2021 to 1 Sep 2021.